GENE ONLINE|News &
Opinion
Blog

2017-12-29|

December 29, 1957: American Immunologist Bruce Beutler Was Born

by GeneOnline
Share To

Bruce Beutler (December 29, 1957 – present) is an American immunologist and geneticist who first discovered cytokine TNFαand applied genetic engineering technique to develop recombinant antibodies which has been widely used in treating various autoimmune diseases. Together with Jules A. Hoffmann, Beutler received one-half of the 2011 Nobel Prize in Physiology or Medicine for their discoveries concerning the activation of innate immunity. Beutler is currently Director of the Center for the Genetics of Host Defense at the University of Texas Southwestern Medical Center in Dallas, Texas, and is professor in the Department of Immunology and chairman of the Department of Genetics at Scripps Research at La Jolla, California.

Reference
https://en.wikipedia.org/wiki/Bruce_Beutler

Image Source
https://en.wikipedia.org/wiki/Bruce_Beutler

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top